On 30 October Jiayuan.com International Ltd. (NASDAQ:DATE) announced that its Board of Directors (“the Board”) has approved the appointment of Mr. Gaofei Wang as an independent director, effective October 30, 2014. Mr. Wang will replace Mr. Jianzhang Liang, an independent director, on the Audit Committee of the Board. Mr. Liang will maintain his position as an independent director and member of the Compensation Committee of the Board. Jiayuan.com International Ltd. (NASDAQ:DATE) in last trading activity advanced 8.05% to close at $5.64. Company weekly performance is 5.42% while its quarterly performance stands at 10.59%. Jiayuan.com International Ltd. (NASDAQ:DATE) is -26.11% away from its 52 week high.
On 5 November QUALCOMM, Inc. (NASDAQ:QCOM) reported net income of $8 billion, or $4.65 per diluted share, for the fiscal year ended Sept. 28, compared to almost $6.9 billion, or $3.91 per share, in the previous fiscal year. On last trading day QUALCOMM, Inc. (NASDAQ:QCOM) advanced 0.93% to close at $70.29. Its volatility for the week is 2.48% while volatility for the month is 1.80%. QCOM’s sales growth for past 5 years was 20.60% and its EPS growth for past 5 years was 32.70%. QUALCOMM, Inc. (NASDAQ:QCOM) monthly performance is -2.18%.
Willamette Valley Vineyards Inc. (NASDAQ:WVVI) Director Delna L. Jones sold 14,000 shares of the company’s stock on the open market in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $5.47, for a total transaction of $76,580.00. Following the sale, the director now directly owns 6,300 shares of the company’s stock, valued at approximately $34,461. On last trading day Willamette Valley Vineyards Inc. (NASDAQ:WVVI) fell -2.54% to close at $5.38. Its volatility for the week is 1.76% while volatility for the month is 2.20%. WVVI’s sales growth for past 5 years was -3.60% and its EPS growth for past 5 years was 15.70%. Willamette Valley Vineyards Inc. (NASDAQ:WVVI) monthly performance is 0.94%.
On 10 November Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) announced that it intends to offer, subject to market and other considerations, $425.0 million aggregate principal amount of Convertible Senior Notes due 2021 (the “Convertible Notes”) in a private placement. Isis also intends to grant to the initial purchasers of the Convertible Notes a 30-day option to purchase up to an additional $63.75 million aggregate principal amount of the Convertible Notes, solely to cover over-allotments, if any. Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) in last trading activity decreased -0.60% to close at $51.08. Company weekly performance is 15.78% while its quarterly performance stands at 39.64%. Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) is -18.48% away from its 52 week high.
On 7 November Whitestone REIT (NYSE:WSR) announced its financial results for the third quarter of 2014. Funds From Operations (“FFO”) Core increased 35%, or approximately $1.8 million, to $6.9 million from $5.1 million. On Wednesday shares of Whitestone REIT (NYSE:WSR) closed at $15.06. Company’s sales growth for last 5 years was 14.80%